05 July 2021>: Articles
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report
Unusual clinical course, Unusual or unexpected effect of treatment
Shigehisa Kubota A , Susumu Kageyama A* , Masayuki Nagasawa C , Akinori Wada B , Ryo Ikari B , Keiji Tomita D , Tetsuya Yoshida A , Mitsuhiro Narita A , Akihiro Kawauchi ADOI: 10.12659/AJCR.930989
Am J Case Rep 2021; 22:e930989
Figure 2. Clinical course after initiation of cabazitaxel chemotherapy. LH-RH – luteinizing hormone-releasing hormone; CBZ – cabazitaxel; PSA – prostate-specific antigen.